Isolda Casanova
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Biotechnology top 5%
- Cancer Research and Treatments
Papers in
-
- Cancer Research and Treatments 8
- Immunology 24
- Immunotherapy and Immune Responses 18
- Toxin Mechanisms and Immunotoxins 8
- Co-authors
- Ramón ManguesMaría Virtudes CéspedesEsther VázquezAntonio VillaverdeUgutz UnzuetaMiguel Ángel PavónPatricia ÁlamoAlberto Gallardo
- Journals
- Pharmaceutics (4 papers)Head & Neck (3 papers)Cancers (3 papers)Acta Biomaterialia (3 papers)Oncotarget (3 papers)
- Partner nations
- SpainArgentinaUnited Kingdom
In The Last Decade
Isolda Casanova
63 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 100
- Oncology 709
- Biotechnology 175
- Immunology 418
- Cancer Research 277
- Biomaterials 232
Countries citing papers authored by Isolda Casanova
This map shows the geographic impact of Isolda Casanova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isolda Casanova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isolda Casanova more than expected).
Fields of papers citing papers by Isolda Casanova
This network shows the impact of papers produced by Isolda Casanova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isolda Casanova. The network helps show where Isolda Casanova may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Isolda Casanova, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 11 | |
| 6 | 2022 | 9 | |
| 7 | 2022 | 11 | |
| 8 | 2022 | 38 | |
| 9 | 2021 | 26 | |
| 10 | 2021 | 20 | |
| 11 | 2020 | 26 | |
| 12 | 2020 | 51 | |
| 13 | 2020 | 16 | |
| 14 | 2019 | 9 | |
| 15 | 2019 | 9 | |
| 16 | 2018 | 28 | |
| 17 | 2018 | 63 | |
| 18 | 2016 | 39 | |
| 19 | 2008 | 16 | |
| 20 | 2006 | 59 |
About Isolda Casanova
Isolda Casanova is a scholar working on Biotechnology, Immunology, Oncology, Otorhinolaryngology and Immunology and Allergy, having authored 67 papers that have together received 1.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (18 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Peptidase Inhibition and Analysis (8 papers), Cancer Research and Treatments (8 papers), Bacteriophages and microbial interactions (8 papers), Toxin Mechanisms and Immunotoxins (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and RNA Interference and Gene Delivery (6 papers). The work is most often cited by research in Oncology (709 citations), Biotechnology (175 citations), Immunology (418 citations), Cancer Research (277 citations) and Biomaterials (232 citations). Isolda Casanova has collaborated with scholars based in Spain, Argentina and United Kingdom. Frequent co-authors include Ramón Mangues, María Virtudes Céspedes, Esther Vázquez, Antonio Villaverde, Ugutz Unzueta, Miguel Ángel Pavón, Patricia Álamo, Alberto Gallardo, Matilde Parreño and Gabriel Capellá. Their work appears in journals such as Pharmaceutics, Head & Neck, Cancers, Acta Biomaterialia and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.